Alife Health Partners with US Fertility to Pilot Embryology Laboratory AI Tools
The Californer/10297759

SAN FRANCISCO and LOS ANGELES, Nov. 19, 2024 ~ In a groundbreaking move, Alife Health (Alife) has announced a new partnership with US Fertility, the largest partnership of physician-owned fertility practices in the United States. Alife, a leading technology company specializing in AI tools for in-vitro fertilization (IVF), will be working with US Fertility clinics to pilot their Embryo Assist™ software.

This partnership aims to revolutionize the IVF process by providing advanced insight into state-of-the-art embryology laboratories. By integrating seamlessly with laboratory microscopes, Alife's Embryo Assist™ allows embryologists to easily capture embryo images and data, elevating laboratory quality-control measures. The tool also generates comprehensive activity and audit trails for each embryo and provides real-time lab updates through its cloud-based platform.

According to Kate Devine, MD, Medical Director and Chief Research Officer of US Fertility, this collaboration marks a significant advancement in their laboratory capabilities. "By integrating AI and data-driven tools into our IVF processes, we aim to continue delivering exceptional care to our patients while providing them with further insight into the precision and consistency of our laboratories," she stated.

More on The Californer

• Long Beach Health Department Hosts Third Annual Kwanzaa Experience Event
• Breaking: Federal Court Says City Of Los Angeles Must Answer Homelessness Lawsuit
• VetsinTech Marks Veterans Day Milestone: 2,000+ Veterans Trained in Cybersecurity Through Craig Newmark Philanthropies Partnership
• Provarity Secures $7 Million in Seed Funding to Transform Presales Enablement
• California invests over $100 million to build safe walking and biking routes in disadvantaged communities

US Fertility is known for its exceptional care and has helped over 225,000 individuals and couples on their journey to build their families through assisted reproductive technology. With more than 200 physicians in fertility centers nationwide, they perform over 50,000 IVF retrieval cycles annually.

The pilot of Embryo Assist™ is expected to further enhance US Fertility's data capabilities and patient integration. Melissa Teran, CEO of Alife Health expressed her excitement about the partnership stating that "Alife is honored to partner with US Fertility to bring our cutting-edge AI solutions into their laboratories." She believes that this collaboration will equip embryologists with a powerful tool that streamlines operations and enhances clinical efficiency.

Together, Alife Health and US Fertility are pushing the boundaries of IVF through innovation. This partnership is a testament to their commitment to providing the best possible care for patients and advancing the field of reproductive technology.

---

Show All News | Report Violation